Atlas FDA

ANGEION SENTINEL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)SYSTEM AND THE ANGEFLEX TM DEFIBRILLATION LEAD SYSTEM.

FDA premarket approval P970024 · decided 1998-08-19

Approval details

PMA number
P970024
Trade name
ANGEION SENTINEL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)SYSTEM AND THE ANGEFLEX TM DEFIBRILLATION LEAD SYSTEM.
Generic name
Implantable cardioverter defibrillator (non-CRT)
Applicant
MicroPort CRM USA, Inc.
Date received
1997-06-19
Decision date
1998-08-19
Days to decision
426 days
Decision code
APWD
Product code
LWS
Advisory committee
Cardiovascular
Expedited review
No
Location
Arlington, TN
Statement
The device is indicated for use in patients who are at risk of sudden death due to ventricular arrhythmias and have experienced one of the following situations: 1) Survival of at least one episode of cardiac arrest (manifested by loss of consciousness) due to a ventricular tachyarrhythmia; and 2) Recurrnet, poolrly tolerated, sustained ventricular tachyarrhythmia.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.